About TearLab Corp (TSE:TLB)
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Symbol: TSE:TLB
- CUSIP: N/A
- Web: www.tearlab.com/
- Market Cap: C$9.3 million
- Outstanding Shares: 5,742,000
- 50 Day Moving Avg: C$1.72
- 200 Day Moving Avg: C$2.40
- 52 Week Range: C$0.51 - C$7.43
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: -0.02
- Annual Revenue: C$28.06 million
- Price / Sales: 0.33
- Book Value: C($2.35) per share
- Price / Book: -0.69
- Average Volume: 11,659 shs.
- Short Ratio: 0.39
Frequently Asked Questions for TearLab Corp (TSE:TLB)
What is TearLab Corp's stock symbol?
TearLab Corp trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TLB."
When will TearLab Corp make its next earnings announcement?
Who are some of TearLab Corp's key competitors?
Some companies that are related to TearLab Corp include AdCare Health Systems (ADK), Delcath Systems (DCTH), Oxford Pharmascience Group Plc (OXP), Evgen Pharma PLC (EVG), Innovus Pharmaceuticals (INNV), Soligenix (SNGX), Xtant Medical Holdings (XTNT), Ampliphi Biosciences Corp (APHB), Synairgen plc (SNG), Concepta PLC (CPT), Proteome Sciences plc (PRM), Ixico Plc (IXI), Akers Biosciences (AKR), InspireMD (NSPR), ValiRx Plc (VAL), 3SBio (SSRX), Aegerion Pharmaceuticals (AEGR) and AEGON (AGN).
Who are TearLab Corp's key executives?
TearLab Corp's management team includes the folowing people:
- Elias Vamvakas, Chairman of the Board
- Joseph S. Jensen, President, Chief Executive Officer, Chief Operating Officer, Director
- Wes Brazell, Chief Financial Officer
- Raymond Kong, Vice President - Sales
- Anthony E. Altig, Independent Director
- Thomas N. Davidson Jr., Independent Director
- Adrienne L. Graves Ph.D., Independent Director
- Paul M. Karpecki, Independent Director
- Richard L. Lindstrom M.D., Independent Director
How do I buy TearLab Corp stock?
Shares of TearLab Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is TearLab Corp's stock price today?
MarketBeat Community Rating for TearLab Corp (TSE TLB)MarketBeat's community ratings are surveys of what our community members think about TearLab Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of TearLab Corp stock can currently be purchased for approximately C$1.62.
Consensus Ratings for TearLab Corp (TSE:TLB) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||N/A|Consensus Price Target History for TearLab Corp (TSE:TLB)
Analysts' Ratings History for TearLab Corp (TSE:TLB)
(Data available from 10/22/2015 forward)
|8/16/2017||HC Wainwright||Reiterated Rating||Buy|
Earnings History for TearLab Corp (TSE:TLB)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for TearLab Corp (TSE:TLB)
Current Year EPS Consensus Estimate: $-0.68 EPS
Dividend History for TearLab Corp (TSE:TLB)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for TearLab Corp (TSE:TLB)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for TearLab Corp (TSE:TLB)
Latest Headlines for TearLab Corp (TSE:TLB)
Loading headlines, please wait.
TearLab Corp (TLB) Chart for Sunday, October, 22, 2017